Meet
Features
Solutions
Pricing
Sales Intelligence
Qualify prospects and connect with decision makers effortlessly
Research Companies & Directors
Make important decisions with absolute confidence
Create B2B Marketing Lists
Target and reach more of your ideal prospects than ever
Monitor Risks & Opportunities
Be the first to learn about changes in the companies that matter
Cleanse Your B2B Database
Instantly transform old records into new opportunities
Perform KYC Checks
Completely understand who you're working with
Discover New Businesses
Identify and connect with new companies as soon as they register
Company Credit Reports
See how companies are performing year–on–year and explore their debts
UPGRADE
Phil Boyd
Phil Boyd was appointed in a total of 2 companies and resigned from 1 of these appointments.
Role
Secretary
Country Of Residence
Unreported
Nationality
Unreported
Date of Birth
Unreported
Occupation
Unreported
Active
1
Resigned
1
Dissolved
0
Other
0
Total
2
Companies
Company
Timeline
Status
Nucleome Therapeutics Limited
Secretary • Unreported
21 Oct 2022
←
2 Years 10 Months
→
Current
Active
Nucleome Therapeutics Limited
Secretary • Unreported
21 Oct 2022
←
1 Year 9 Months
→
26 Jul 2024
Active
Mutual People
DR Fiona Caroline Maclaughlin
Nucleome Therapeutics Limited
is a mutual company.
DR Jonathan Paul Hepple
Nucleome Therapeutics Limited
is a mutual company.
Mr Lachlan Tom Mackinnon
Nucleome Therapeutics Limited
is a mutual company.
Dr Danuta Mariola Jeziorska
Nucleome Therapeutics Limited
is a mutual company.
James Raymond Hughes
Nucleome Therapeutics Limited
is a mutual company.
DR Bauke Anninga
Nucleome Therapeutics Limited
is a mutual company.
Financials, Credit Activity, Owners, and more
Completely understand the businesses you work with
Make key decisions on clients and suppliers faster, discover leads and connect with decision makers, and easily monitor opportunities that get better through time
EXPLORE ENDOLE APP